Optimi Health To Launch Therapeutic Psilocybin Product In Partnership With Patient...

PT345 – Steve Thayer, Ph.D. – Vital Psychedelic Conversations

Buried Treasure: How Does Psilocybin Reduce Compulsivity?

Field Trip Health Ltd. Schedules Fiscal First Quarter 2023 Conference Call...

Psychedelic Bulletin #113 – Analysis of Company Spending Trends; Morgan Stanley...

New 3D Structures of Cannabinoid Receptor Inform Safer Drug Design

PT344 – Susan Beaulieu – Epigenetics, Resilience, and Remembering

MindMed Board of Directors Approves Reverse Share Split

COMPASS Pathways plc announces second quarter 2022 financial results and business...

MindMed to Participate in the Canaccord Genuity 42nd Annual Growth Conference

Load more